Emory Center for Neurodegenerative Disease’s (CND) overriding goal is to make major research discoveries that will help transform neurodegenerative disorders from poorly treatable, inevitable, and incurable conditions to treatable, preventable and curable conditions. Over 40 laboratories work collaboratively to integrate fundamental, translational and clinical research findings, all towards enhancing our understanding of devasting neurodegenerative disease such as Alzheimer's disease (AD), Parkinson disease (PD), ALS, frontal temporal dementia (FTD) and other related disorders. The CND also serves as a hub for training the next generation of scientists in a dynamic environment. As part of its educational mission, the CND trains a wide range of undergraduate, graduate students and postdoctoral fellows and junior faculty. 

Laboratory  

CND has 5,000 square feet of space in Health Sciences Research Building II and ~12,000 square feet of space in the Whitehead Biomedical Research Building. Its research laboratories and core facilities are equipped with the most advanced technologies in imaging, proteomics, gene expression analysis, viral vectors and gene therapy, monoclonal antibodies, and histopathology. Functioning as a center without walls, the CND’s members have labs outside this allotted space, and the CND hosts the Emory Proteomics Core and Neuropathology Core. 

Office  

Each PI has offices near their laboratories, ranging from 120-200 square feet.  

Other 

Beyond the research, CND maintains a strong partnership with Emory Healthcare, which has a large and outstanding clinical faculty providing comprehensive care, education, and support for affected individuals and their families.